Bridget Carey
Neurology · New York, NYNPI 1417998436
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations.
Across 93 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$402
- Mannkind Corporation$397
- Lilly USA, LLC$224
- GRT US Holding, Inc.$166
- Medtronic$140
- Grifols USA, LLC$107
- plus $553 from 15 others
What the payments were for
- Food & beverage$1,989100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 22 | $402 |
| Mannkind Corporation | 20 | $397 |
| Lilly USA, LLC | 12 | $224 |
| GRT US Holding, Inc. | 3 | $166 |
| Medtronic | 1 | $140 |
| Grifols USA, LLC | 6 | $107 |
| Biogen | 5 | $101 |
| Currax Pharmaceuticals LLC | 4 | $69 |
| Argenx US, Inc. | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Novo Nordisk | 3 | $53 |
| Nevro Corp. | 2 | $48 |
| Cequr Corporation | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $16 |
| AbbVie | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,989 in reported general payments places this provider in the 60th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 17 | $197,510 |
| Gabapentin | 22 | $950 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 25 | $548 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 11 | $146 |
| Donepezil Hcl | 15 | $106 |
Paid to pharmacies, not to this prescriber.
Other neurology in New York
- Stephen KriegerNew York$1.1M
- Sheng-Han KuoNew York$657K
- Timothy VartanianNew York$468K
- Steven WolfNew York$428K
- David DodickNew York$426K
- David SimpsonNew York$403K
- Fred LublinNew York$383K
- Alexander ShtilbansNew York$374K
- Andrew LassmanNew York$359K
- Brian ApatoffNew York$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.